According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are โฌ85.58 M. In 2023 the company made an earning of -โฌ55.26 M a decrease over its 2022 earnings that were of โฌ0.18 B.The earnings displayed on this page is the company's Pretax Income.